A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
Huiping Li(Peking University), Erwei Song(Sun Yat-sen University)
Cited by 106
Related Papers
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|699
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
|Journal of Biological Chemistry|2011|309
miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program
|Nature Communications|2015|261
Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer
|New England Journal of Medicine|2024|235
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
|Cell Research|2017|225